AIM

AMEX · Biotechnology

Aim Immunotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.96

+0.04 (+4.46%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +2,204.7% upside

Low Target $15.13

Average Target $22.10

High Target $31.02

Current Price $0.96

Current
$0.96

Target
$22.10

$15.13 $22.10 avg $31.02

Scenario Analysis

Bear Case

$15.13

1,477.8%

Low target

Base Case

$22.10

+2,204.7%

Avg target

Bull Case

$31.02

+3,135.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$34.89

-97.3% from high

52-Week Low

$0.61

+56.1% from low

Target vs 52W High

$22.10

-36.7% vs high

Next Earnings Report

Mar 30, 2026 · After Market Close

until earnings

EPS Est: $-0.97

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+22.0%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+163.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.9%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.9%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.2%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%